Ovarian Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Ovarian Cancer, including details on symptoms, causes, treatment, information.

Volume 5 (2008), Issue 7 (July)

1. Unusual case of adenocarcinoma arising in endometriosis mimicking colorectal cancer in a young woman with a Müllerian anomaly.
   Fertil Steril, 90(1): 199.e13-5. [Abstract] [Full-text]
2. Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel.
   Clin Cancer Res, 14(13): 4200-5. [Abstract] [Full-text]
3. Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma.
   Clin Cancer Res, 14(13): 4067-78. [Abstract] [Full-text]
4. Multiple loci with different cancer specificities within the 8q24 gene desert.
   J Natl Cancer Inst, 100(13): 962-6. [Abstract] [Full-text]
5. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
   Am J Surg Pathol, 32(7): 1029-37. [Abstract] [Full-text]
6. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.
   Am J Surg Pathol, 32(7): 955-64. [Abstract] [Full-text]
7. Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients.
   Brain Behav Immun, 22(6): 890-900. [Abstract] [Full-text]
8. Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study.
   J Clin Oncol, 26(20): 3418-25. [Abstract] [Full-text]
9. Abdominal hypertension in Meigs' syndrome.
   Eur J Surg Oncol, 34(8): 938-42. [Abstract] [Full-text]
10. The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer.
    Br J Cancer, 99(2): 341-9. [Abstract] [Full-text]
11. Chemosensitisation by manganese superoxide dismutase inhibition is caspase-9 dependent and involves extracellular signal-regulated kinase 1/2.
    Br J Cancer, 99(2): 283-93. [Abstract] [Full-text]
12. Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.
    Cancer Res, 68(14): 5849-58. [Abstract] [Full-text]
13. Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.
    Cancer Res, 68(14): 5839-48. [Abstract] [Full-text]
14. Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion.
    Cancer Res, 68(14): 5716-23. [Abstract] [Full-text]
15. The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects.
    Cancer Res, 68(14): 5658-68. [Abstract] [Full-text]
16. Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer.
    J Clin Oncol, 26(21): 3598-606. [Abstract] [Full-text]
17. Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion.
    Radiology, 248(2): 511-7. [Abstract] [Full-text]
18. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary.
    Gynecol Oncol, 110(2): 125-32. [Abstract] [Full-text]
19. A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer.
    Gynecol Oncol, 110(2): 140-5. [Abstract] [Full-text]
20. The role of regular physical examination in the detection of ovarian cancer recurrence.
    Gynecol Oncol, 110(2): 158-61. [Abstract] [Full-text]
21. Novel perioperative imaging with 18F-FDG PET/CT and intraoperative 18F-FDG detection using a handheld gamma probe in recurrent ovarian cancer.
    Gynecol Oncol, 110(2): 152-7. [Abstract] [Full-text]
22. Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: a phase II trial of the Puget Sound Oncology Consortium.
    Gynecol Oncol, 110(2): 146-51. [Abstract] [Full-text]
23. Increased expression of Nlp, a potential oncogene in ovarian cancer, and its implication in carcinogenesis.
    Gynecol Oncol, 110(2): 230-6. [Abstract] [Full-text]
24. S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.
    Gynecol Oncol, 110(2): 237-45. [Abstract] [Full-text]
25. In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.
    Gynecol Oncol, 110(2): 246-50. [Abstract] [Full-text]
26. Progesterone facilitates cisplatin toxicity in epithelial ovarian cancer cells and xenografts.
    Gynecol Oncol, 110(2): 251-5. [Abstract] [Full-text]
27. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors.
    Gynecol Oncol, 110(2): 162-7. [Abstract] [Full-text]
28. Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?
    Gynecol Oncol, 110(2): 133-9. [Abstract] [Full-text]
29. First report of ovarian dysgerminoma in Cowden syndrome with germline PTEN mutation and PTEN-related 10q loss of tumor heterozygosity.
    Am J Surg Pathol, 32(8): 1258-64. [Abstract] [Full-text]

© 2004-2008 Ovarian Cancer Research Today. All Rights Reserved.